FDA sees benefits of linking universal device IDs to EHRs
The Food and Drug Administration contends that universal device identifiers will enable the agency to actively monitor medical device performance and better identify patient safety concerns and recalls.

Amy Abernethy, chief medical officer and senior vice president of oncology at Flatiron Health Inc., speaks during a Bloomberg Live panel discussion in Washington, D.C., U.S., on Tuesday, Sept. 19, 2017. The event is titled The Future of Health Care: Unlocking & Supporting Value. Photographer: Andrew Harrer/Bloomberg
More for you
See AllLoading data for hdm_tax_topic #better-outcomes...